Features of MMR markers expression (MSH2, MSH6, MLH1, PMS2) in endometrioid adenocarcinoms of the endometria

Authors

DOI:

https://doi.org/10.26641/1997-9665.2026.1.41-47

Keywords:

endometrioid endometrial adenocarcinoma, marker MSH2, MSH6, MLH1 and PMS2.

Abstract

Topicality. Endometrial adenocarcinoma is one of the most common malignant neoplasms of the female reproductive system, for which modern approaches to diagnosis are based on a combination of morphological and molecular genetic characteristics of the tumor. Of particular importance is the determination of the deficiency of the mismatch repair system (MMR) and microsatellite instability, which is associated with Lynch syndrome, the prognosis of the disease and the possibility of using targeted and immunotherapy. The purpose. To determine the features of the expression of MMR markers (MSH2, MSH6, MLH1, PMS2) in endometrioid endometrial adenocarcinomas depending on the degree of morphological atypism and to assess their value as additional prognostic and diagnostic criteria. Methods. A retrospective analysis of postoperative material from 60 cases of endometrioid adenocarcinoma of the endometrium obtained in the morphological department of the diagnostic center of Dnipro for the period 2021–2024 was conducted. Immunohistochemical study was performed on formalin-fixed and paraffin-embedded material using the Lab Vision Quanto and DAB Quanto Chromogen imaging systems according to the WHO classification (2020). The studied cases were divided into three groups depending on the degree of tumor differentiation: grade 1, grade 2 and grade 3. Results. The average age of the patients was 54.30±10.68 years in the grade 1 group, 58.80±9.04 years in grade 2 and 58.67±10.46 years in grade 3. It was found that MSH2 expression was observed in 93.3% of grade 1 cases, 90% in grade 2 and 50% in grade 3, while MSH6 expression was 93.3%, 86.7% and 46.7%, respectively. At the same time, the absence of MLH1 and PMS2 expression in grade 1 was 96.3%, decreasing to 63.3% in grade 2 and 23.3% in grade 3, which indicates an increase in the expression of these markers with increasing malignancy. Statistically significant differences in the expression of MMR markers between groups of different degrees of differentiation were found (p<0.001). Also, concordance of marker expression in pairs MSH2/MSH6 and MLH1/PMS2 was established. Conclusion. The need to use a panel of MSI markers: MSH2, MSH6, MLH1 and PMS2 in endometrioid endometrial adenocarcinomas as prognostic and diagnostic markers is argued.

References

  1. Xiao JP, Wang JS, Zhao YY, Du J, Wang YZ. Microsatellite instability as a marker of prognosis: a systematic review and meta-analysis of endometrioid endometrial cancer survival data. Arch Gynecol Obstet. 2023;307(2):573-82. doi: 10.1007/s00404-022-06636-8.
  2. Espinosa I, D'Angelo E, Prat J. Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging. Gynecol Oncol. 2024;186:94-103. doi: 10.1016/j.ygyno.2024.04.008.
  3. Evrard C, Alexandre J. Predictive and Prognostic Value of Microsatellite Instability in Gynecologic Cancer (Endometrial and Ovarian). Cancers (Basel). 2021;13(10):2434. doi: 10.3390/cancers13102434.
  4. Umegaki S, Takahashi M, Hasegawa-Minato J, Kawamura M, Taniguchi S, Komine K, Tokunaga H, Ouchi K, Imai H, Saijo K, Shirota H, Fujishima F, Shimada M, Aoki Y, Ishioka C. Coexisting germline variants of MLH1 and MSH6 in a patient with Lynch syndrome who had uterine and ovarian cancer. Int Cancer Conf J. 2025;14(2):171-6. doi: 10.1007/s13691-025-00753-2.
  5. Zhao S, Chen L, Zang Y, Liu W, Liu S, Teng F, Xue F, Wang Y. Endometrial cancer in Lynch syndrome. Int J Cancer. 2022;150(1):7-17. doi: 10.1002/ijc.33763.
  6. Kim SR, Tone A, Kim RH, Cesari M, Clarke BA, Eiriksson L, Hart T, Aronson M, Holter S, Lytwyn A, Lajkosz K, Oldfield L, Gallinger S, Bernardini MQ, Oza AM, Djordjevic B, Lerner-Ellis J, Van de Laar E, Vicus D, Pugh T, Pollett A, Ferguson SE. Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study. Gynecol Oncol. 2021;161(1):221-7. doi: 10.1016/j.ygyno.2021.01.002.
  7. Ruz-Caracuel I, López-Janeiro Á, Heredia-Soto V, Ramón-Patino JL, Yébenes L, Berjón A, Hernández A, Gallego A, Ruiz P, Redondo A, Peláez-García A, Mendiola M, Hardisson D. Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma. Virchows Arch. 2021;479(6):1167-76. doi: 10.1007/s00428-021-03176-5.
  8. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4. doi: 10.1001/jama.2013.281053.
  9. Vareniuk IM, Dzerzhynskyi ME. [Methods of cyto-histological diagnosis]. Kyiv: Interservis; 2019. 256 p. Ukrainian.
  10. Nguyen T. Immunohistochemistry: A Technical Guide to Current Practices. Cambridge: Cambridge University Press; 2022. 282 p.
  11. Kurrman RJ, Carcangiu ML, Herrington CS, Young RH. WHO Classification of tumors of female reproductive organs. Lyon: IARC; 2020. 631 p.
  12. Petrovska I, Salyha Y, Vudmaska I. [Statistical methods in biological research: educational and methodological manual]. Kyiv: Agrarian science; 2022. 172 p. Ukrainian.
  13. Kim SR, Pina A, Albert A, McAlpine JN, Wolber R, Gilks B, Carey MS, Kwon JS. Mismatch repair deficiency and prognostic significance in patients with low-risk endometrioid endometrial cancers. Int J Gynecol Cancer. 2020;30(6):783-8. doi: 10.1136/ijgc-2019-000910.
  14. Kurpiel B, Thomas MS, Mubeen M, Ring KL, Modesitt SC, Moskaluk CA, Mills AM. MLH1/PMS2-deficient Endometrial Carcinomas in a Universally Screened Population: MLH1 Hypermethylation and Germline Mutation Status. Int J Gynecol Pathol. 2022;41(1):1-11. doi: 10.1097/PGP.0000000000000767.
  15. Sharma R, Badwal S, Dhawan S. Exploring Microsatellite Instability in Endometrial Carcinomas: Clinicopathological Correlations and Clinical Implications-A Study from North India. Indian J Surg Oncol. 2026;17(1):80-9. doi: 10.1007/s13193-025-02303-x.

Downloads

Published

2026-03-27

How to Cite

Savchenko , P. (2026). Features of MMR markers expression (MSH2, MSH6, MLH1, PMS2) in endometrioid adenocarcinoms of the endometria. Морфологія / Morphologia / Morfologìâ, 20(1), 41–47. https://doi.org/10.26641/1997-9665.2026.1.41-47

Issue

Vol. 20 No. 1 (2026)

Section

Статті

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.
        By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world. 
        The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.